Chat with us, powered by LiveChat Publications | Page 3 Of 18 | Lhasa Limited
Lhasa Logo

Publications

Read our latest publications

Filter by:

Solution

Publications Specific Solution Area

Publication Type

Date

  1. Paper

    Applicability of the ICH M7 Guidelines for Assessing Less-than-Lifetime Exposure to Nitrosamine Impurities in Drug Products

    • Sep 2026
    • Genotoxic impurity evaluation, In silico mutagenicity assessment, Nitrosamine impurity risk assessment

  2. Paper

    Toxicological assessment of potential leachables in parenteral drug products: Bioavailability adjustment considerations

    • Aug 2026
    • AI/PDE

  3. Paper

    Industrial Genotoxicology Group: 38th Annual Meeting Report

    • Jul 2026
    • Genotoxic impurity evaluation

  4. Paper

    Which carcinogenicity study should I use? Automated identification of reliable studies

    • Jun 2026
    • Carcinogenicity assessment, Data sharing, NAMs Strategy, UK Government Replacing Animals In Science Strategy

  5. Paper

    In silico prediction of Ames mutagenicity for organosilicon compounds: Exploring and enhancing chemical space boundaries

    • Jun 2026
    • Data sharing, In silico mutagenicity assessment, NAMs Strategy

  6. Paper

    Translating Ambition Into Reality: A Collaborative Industry-led Framework For The UK Government Replacing Animals In Science Strategy

    • Jun 2026
    • NAMs Strategy, Roadmap towards phasing out animal testing, UK Government Policy

  7. Infographic

    Confident toxicity assessments, enabled by Lhasa Limited

    • Apr 2026
    • Genotoxic impurity evaluation, In silico mutagenicity assessment, Non-genotoxic impurity assessment

  8. Paper

    Analysis of nitrite in pharmaceutical excipients: A multi‑laboratory comparative study

    • Apr 2026
    • Data sharing, Nitrites

  9. Paper

    Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data

    • Feb 2026
    • Carcinogenicity assessment, Nitrosamine impurity risk assessment

  10. Paper

    Establishing Best Practice for N-Nitrosamine Read-Across and Surrogate Selection

    • Dec 2025
    • AI/PDE, Complex Nitrosamines, Nitrosamine impurity risk assessment, Safety profiling in drug discovery

  11. Paper

    Development of a Skin Sensitization Site-of-Contact Exposure Threshold (SoCET) for Botanicals and Natural Substances

    • Nov 2025
    • Skin sensitisation assessment

  12. Paper

    Evaluating the ability of defined approaches to predict the human skin sensitisation potential of chemicals previously untested in new approach methodologies

    • Nov 2025
    • Skin sensitisation assessment